In R218Q KI mice challenged with puromycin aminonucleoside, dynein-mediated mistrafficking and depletion of nephrin were correlated with increased Dynll1-PI31 interaction; the resulting podocytopathy and FSGS were ameliorated by bortezomib. Here, DYNLL1 is linked to focal segmental glomerulosclerosis.